Table 4. Adjusted Hazard Ratios (aHR) on patient mortality and graft failure^*.

Characteristics at transplant		Patient mortality				Graft failure
		aHR	95% CI		P value	aHR	95% CI		P value
Age		1.019	1.017	1.02	<.0001	1.009	1.008	1.01	<.0001
Gender (Ref = Male)	Female	0.894	0.867	0.922	<.0001	0.897	0.871	0.924	<.0001
Race (Ref = White)	Asian	0.699	0.645	0.757	<.0001	0.712	0.66	0.768	<.0001
	Black	1.258	1.201	1.318	<.0001	1.267	1.213	1.324	<.0001
	Hispanic	0.878	0.839	0.92	<.0001	0.895	0.857	0.935	<.0001
	Others/Unknown	0.985	0.859	1.13	0.83	0.969	0.851	1.103	0.63
Body Mass Index		0.994	0.992	0.997	<.0001	0.996	0.993	0.998	0.0007
MELD score		0.994	0.992	0.996	<.0001	0.994	0.992	0.996	<.0001
Dialysis prior week to transplant (Ref = N)	Yes	1.337	1.261	1.417	<.0001	1.303	1.233	1.378	<.0001
Diabetes type 2 (Ref = N)	Yes	1.165	1.122	1.21	<.0001	1.112	1.072	1.153	<.0001
Albumin		0.941	0.922	0.96	<.0001	0.936	0.918	0.954	<.0001
Encephalopathy is 3–4 (Ref = N)	Yes	1.115	1.065	1.167	<.0001	1.083	1.037	1.132	0.0004
KPS categories at (Ref = 80–100)	10–40	1.184	1.126	1.244	<.0001	1.109	1.058	1.162	<.0001
	50–70	1.11	1.069	1.152	<.0001	1.076	1.039	1.114	<.0001
Donor Risk Index		1.274	1.236	1.313	<.0001	1.346	1.309	1.385	<.0001
Medical condition (Ref = Not hospitalized)	Hospitalized not in ICU	1.072	1.02	1.128	0.006	1.073	1.023	1.126	0.004
	In intensive care unit	1.289	1.21	1.372	<.0001	1.304	1.23	1.384	<.0001

*Clinical variables at the time of liver transplantation.

KPS—Karnofsky Performance Status; MELD—model for end-stage liver disease.